CoChat
Sign Up
Cited by 269

The DOI matches its Crossref record.

Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site

Xu, Jinbin, Zeng, Chenbo, Chu, Wenhua, Pan, Fenghui, Rothfuss, Justin M., Zhang, Fanjie, Tu, Zhude, Zhou, Dong, Zeng, Dexing, Vangveravong, Suwanna, Johnston, Fabian, Spitzer, Dirk, Chang, Katherine C., Hotchkiss, Richard S., Hawkins, William G., Wheeler, Kenneth T., Mach, Robert H.·2011·Nature Communications
DOI 10.1038/ncomms1386PMC PMC3624020
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms1386

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. Hellewell, S. B. et al. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol. 268, 9–18 (1994). · DOI · Paper page
  2. Hanner, M. et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc. Natl Acad. Sci. USA 93, 8072–8077 (1996). · DOI
  3. Matsumoto, R. R., Liu, Y., Lerner, M., Howard, E. W. & Brackett, D. J. Sigma receptors: potential medications development target for anti-cocaine agents. Eur. J. Pharmacol. 469, 1–12 (2003). · DOI
  4. Takebayashi, M., Hayashi, T. & Su, T. P. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants. J. Pharmacol. Exp. Ther. 303, 1227–1237 (2002). · DOI
  5. Hayashi, T. et al. Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering Rats. J. Pharmacol. Exp. Ther. 332, 1054–1063 (2009). · DOI
  6. Maurice, T. & Su, T. P. The pharmacology of sigma-1 receptors. Pharmacol. Ther. 124, 195–206 (2009). · DOI · Paper page
  7. Mavlyutov, T. A., Epstein, M. L., Andersen, K. A., Ziskind-Conhaim, L. & Ruoho, A. E. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 167, 247–255 (2010). · DOI
  8. Wu, Z. & Bowen, W. D. Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells. J. Biol. Chem. 283, 28198–28215 (2008). · DOI
  9. Mach, R. H. et al. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 57, 156–161 (1997).
  10. Al-Nabulsi, I. et al. Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells. Br. J. Cancer 81, 925–933 (1999). · DOI
  11. Wheeler, K. T. et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br. J. Cancer 82, 1223–1232 (2000). · DOI · Paper page
  12. Chu, W. et al. New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents. Bioorg. Med. Chem. 17, 1222–1231 (2009). · DOI
  13. Hornick, J. R. et al. The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine. Mol. Cancer 9, 298 (2010). · DOI
  14. Kashiwagi, H. et al. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy. Mol. Cancer 6, 48 (2007). · DOI
  15. Mach, R. H., Dehdashti, F. & Wheeler, K. T. PET radiotracers for imaging the proliferative status of solid tumors. PET Clin. 4, 1–15 (2009). · DOI
  16. Mach, R. H. & Wheeler, K. T. Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo. Cent. Nerv. Syst. Agents Med. Chem. 9, 230–245 (2009). · DOI
  17. Tu, Z. et al. Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer. Nucl. Med. Biol. 32, 423–430 (2005). · DOI
  18. Tu, Z. et al. Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography. J. Med. Chem. 50, 3194–3204 (2007). · DOI
  19. Tu, Z. et al. Radiosynthesis and biological evaluation of a promising sigma(2)-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET/SPECT probe for imaging breast cancer. Appl. Radiat. Isot. 68, 2268–2273 (2010). · DOI
  20. Xu, J. et al. [3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5 -methylbenzamide: a novel sigma-2 receptor probe. Eur. J. Pharmacol. 525, 8–17 (2005). · DOI
  21. Zeng, C. et al. Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes. Molecular Imaging (e-pub ahead of print 27 April) (2011). · DOI
  22. Zeng, C. et al. Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. Cancer Res. 67, 6708–6716 (2007). · DOI
  23. Cahill, M. A. Progesterone receptor membrane component 1: an integrative review. J. Steroid Biochem. Mol. Biol. 105, 16–36 (2007). · DOI
  24. Peluso, J. J., Liu, X., Gawkowska, A., Lodde, V. & Wu, C. A. Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression. Mol. Cell Endocrinol. 320, 153–161 (2010). · DOI
  25. Rohe, H. J., Ahmed, I. S., Twist, K. E. & Craven, R. J. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol. Ther. 121, 14–19 (2009). · DOI · Paper page
  26. Neubauer, H. et al. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells. Climacteric 12, 230–239 (2009). · DOI
  27. Intlekofer, K. A. & Petersen, S. L. Distribution of mRNAs encoding classical progestin receptor, progesterone membrane components 1 and 2, serpine mRNA binding protein 1, and progestin and ADIPOQ receptor family members 7 and 8 in rat forebrain. Neuroscience 172, 55–65 (2011). · DOI
  28. Suchanek, M., Radzikowska, A. & Thiele, C. Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells. Nat. Methods 2, 261–267 (2005). · DOI
  29. Szczesna-Skorupa, E. & Kemper, B. Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductase. Mol. Pharmacol. 79, 340–350 (2011). · DOI
  30. Yang, T. et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110, 489–500 (2002). · DOI · Paper page
  31. Peluso, J. J., Pappalardo, A., Losel, R. & Wehling, M. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. Endocrinology 147, 3133–3140 (2006). · DOI
  32. Ahmed, I. S., Rohe, H. J., Twist, K. E. & Craven, R. J. Pgrmc1 (progesterone receptor membrane component 1) associates with EGFR and regulates erlotinib sensitivity. J. Biol. Chem. 285, 24775–24782 (2010). · DOI
  33. Ahmed, I. S., Rohe, H. J., Twist, K. E., Mattingly, M. N. & Craven, R. J. Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule. J. Pharmacol. Exp. Ther. 333, 564–573 (2010). · DOI
  34. Chen, J. I. et al. Proteomic characterization of midproliferative and midsecretory human endometrium. J. Proteome. Res. 8, 2032–2044 (2009). · DOI
  35. Gebreselassie, D. & Bowen, W. D. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. Eur. J. Pharmacol. 493, 19–28 (2004). · DOI
  36. Vilner, B. J., John, C. S. & Bowen, W. D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 55, 408–413 (1995).
  37. Yoshitani, N. et al. A structure-based strategy for discovery of small ligands binding to functionally unknown proteins: combination of in silico screening and surface plasmon resonance measurements. Proteomics 5, 1472–1480 (2005). · DOI
  38. Jonhede, S., Petersen, A., Zetterberg, M. & Karlsson, J. O. Acute effects of the sigma-2 receptor agonist siramesine on lysosomal and extra-lysosomal proteolytic systems in lens epithelial cells. Mol. Vis. 16, 819–827 (2010).
  39. Vangveravong, S., Xu, J., Zeng, C. & Mach, R. H. Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands. Bioorg. Med. Chem. 14, 6988–6997 (2006). · DOI
  40. Perregaard, J., Moltzen, E. K., Meier, E. & Sanchez, C. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles. J. Med. Chem. 38, 1998–2008 (1995). · DOI

Cited by

Sorted by citations

Metadata

Authors
Xu, J., Zeng, C., Chu, W., Pan, F., Rothfuss, J. M., Zhang, F., Tu, Z., Zhou, D., Zeng, D., Vangveravong, S., Johnston, F., Spitzer, D., Chang, K. C., Hotchkiss, R. S., Hawkins, W. G., Wheeler, K. T., & Mach, R. H.
Venue
Nature Communications
Publisher
Springer Science and Business Media LLC
Published
2011-07-05
Volume
2
Issue
1
ISSN
2041-1723
DOI
10.1038/ncomms1386
PMC
PMC3624020
Cited by
269
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review